Feasibility and Safety of a Combined Augmented Reality and Functional Electrical Stimulation System

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity Health Network, Toronto

About this trial

Cervical spinal cord injury (cSCI) can result in substantial loss of upper-limb function, with associated socio-economic impact on affected individuals and the healthcare system. Evidence suggests that non-invasive neuromodulation such as functional electrical stimulation (FES) therapy can contribute to regaining upper-limb function, which is a top priority for this population. This pilot study will involve individuals with cSCI using a device that combines augmented reality (AR) and functional electrical stimulation (FES) for 20, one-hour sessions over a 10-week period. The sessions will include upper-limb rehabilitation where individuals will interact with different objects with the aid of the AR +FES system. The primary objective is to assess safety and feasibility, measured by the absence of serious adverse events and participants' ability to independently set up and use the system. Secondary objectives include adherence to the intervention and user feedback through structured interviews. Exploratory outcomes will examine preliminary efficacy using clinical measures such as the Spinal Cord Independence Measure (SCIM) and the Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Chronic cervical SCI

Any level or severity of cervical SCI, traumatic or non-traumatic

Can carry out object manipulations but with visible impairment (i.e., 5-25 on the GRASSP Prehension Performance sub-score).

Disqualifiers

Any disease or injury other than the SCI that may be affecting grasping performance.

Individuals with any self-reported FES contraindications (pacemakers, implantable defibrillator, implanted neurostimulation device, metallic implants in the stimulated areas, cardiac conditions, epilepsy, uncontrolled seizures, wounds or fractures on the target limb)

Inability to understand the study procedures

Muscles do not respond to FES to produce grasping movements

Trial design

Design model

Single group

Treatments tested in this trial

  • AR + FES

    Device

    Within each one-hour experimental session, participants will interact with different objects (e.g. block, credit card, marble). They will be wearing an augmented reality (AR) headset and electrodes will be placed over finger flexors, thumb flexors and finger extensors muscles. The AR headset will track hand posture and use the difference between the actual posture and a target posture to regulate functional electrical stimulation (FES) delivered via the electrodes.

Treatment groups

7 Participants
are divided into 1 treatment group
Group A: Single groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Adverse events

Presence of adverse and serious adverse events. These will be recorded during each session. The criterion for success is no study-related serious adverse events and no study-related adverse events that cannot be alleviated by stopping electrical stimulation.

Time frame
Week 1 to week 14.
2

Feasibility - Set-up time

The study will track independence with the system by assessing set-up time.

Time frame
During experimental sessions from week 1 to week 10.
3

Feasibility - Assistance required.

The study will track independence with the system by assessing the number of times assistance is requested.

Time frame
During experimental sessions from week 1 to week 10.

Secondary outcomes

1

Adherence

Number of missed sessions.

Time frame
During experimental sessions from week 1 to week 10.
2

User feedback

Structured and semi-structured interviews.

Time frame
Discharge assessment at week 10.

Other outcomes

1

Graded Redefined Assessment of Strength, Sensation and Prehension

Hand function assessment.

Time frame
Baseline (week 0), discharge (week 10) and follow-up (week 14) assessments.
2

Spinal Cord Independence Measure

Questionnaire about independence on daily tasks.

Time frame
Baseline (week 0), discharge (week 10) and follow-up (week 14) assessments.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Health Network, Toronto

Lead sponsor

Canadian Training Platform for Trials Leveraging Existing Networks

Collaborator